New modes of action of desferrioxamine: Scavenging of semiquinone radical and stimulation of hydrolysis of tetrachlorohydroquinone

Free Radical Biology and Medicine

Volumn 24, Issue 2, 1998, Pages 360-369

  Zhu, Ben Zhan ^a   Har El, Ronit ^a   Kitrossky, Nahum ^a   Chevion, Mordechai ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Desfemoxamine (Desferal , deferoxamine); Desfernoxamine nitroxide radical; Hydrolysis; Semiquinone radical scavenger; Tetrachloro 1,4 benzoquinone (chloranil). 2.5 dichloro 3,6 dihydroxy 1.4 benzoquinone (chloranilic acid); Tetrachlorohydroquinone; Tetrachlorosemiquinone radical

Indexed keywords

DEFEROXAMINE; DEFEROXAMINE MESYLATE; RADICAL; SEMIQUINONE; TETRACHLOROHYDROQUINONE;

ANIMAL CELL; ARTICLE; AUTOOXIDATION; BINDING AFFINITY; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG MECHANISM; HALOGENATION; HUMAN; HUMAN CELL; IRON CHELATION; IRON METABOLISM; IRON OVERLOAD; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

BENZOQUINONES; CHLORANIL; DEFEROXAMINE; DNA DAMAGE; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; FREE RADICALS; HYDROLYSIS; HYDROQUINONES; IRON CHELATING AGENTS; NITROGEN OXIDES; OXIDATION-REDUCTION; PENTETIC ACID;

ANIMALIA;

EID: 0031963830     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00220-7     Document Type: Article

References (55)

1. Mclaren G. D., Muir W. A., Kellermeyer R. W. Iron overload disorders: Natural history, pathogenesis, diagnosis and therapy. CRC Crit. Rev. Clin. Lab. Sci. 19:1983;205-265.
2. Giardina P. J., Grady R. W. Chelation therapy in β-thalassemia: The benefits and limitations of desferrioxamine. Seminars Hematol. 32:1995;304-312.
3. Gabutti V., Piga A. Results of long-term iron-chelating therapy. Acta Haematol. 95:1996;26-36.
4. Keberle H. The biochemistry of desferrioxamine and its relation to iron metabolism. Ann. N.Y. Acad. Sci. 119:1964;758-768.
5. Gutteridge J. M. C., Richmond R., Halliwell B. Inhibition of the iron-catalyzed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamine. Biochem. J. 184:1979;469-472.
6. Graf E., Mahoney J. R., Bryant R. G., Eaton J. W. Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site. J. Biol. Chem. 259:1984;3620-3624.
7. Eaton J. W. Iron: The essential poison. Redox Report. 2:1996;215.
8. Marx J. J. M., Van Asbeck B. S. Use of iron chelators in preventing hydroxyl radical damage: Adult respiratory distress syndrome as an experimental model for the pathophysiology and treatment of oxygen-radical-mediated tissue damage. Acta Haematol. 95:1996;49-62.
9. Halliwell B. Protection against tissue damage in vivo by desferrioxamine: What is its mechanism of action? Free Rad. Biol. Med. 7:1989;645-651.
10. Hershko C., Pinson A., Link G. Prevention of anthracycline cardiotoxicity by iron chelation. Acta Haematol. 95:1996;87-92.
11. Kontoghiorghes G. J. Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugs. Toxicol. Lett. 80:1995;1-18.
12. Hoe S., Rowley D. A., Halliwell B. Reactions of ferrioxamine and desferrioxamine with the hydroxyl radical. Chem-Biol. Interact. 41:1982;75-81.
13. Halliwell B. Use of desferrioxamine as a "probe" for the iron-dependent formation of hydroxyl radicals. Evidence for a direct reaction between desferal and the superoxide radical. Biochem. Pharmacol. 34:1985;229-233.
14. Goldstein S., Czapski G. A reinvestigation of the reaction of desferrioxamine with superoxide radicals. A pulse radiolysis study. Free Rad. Res. Comm. 11:1990;231-240.
15. Davies M. J., Donkor R., Dunster C. A., Gee C. A., Jonas S., Wilson R. L. Desferrioxamine and superoxide radicals. Formation of an enzyme-damaging nitroxide. Biochem. J. 246:1987;725-729.
16. Darley-Usmar V. M., Hersey A., Garland L. G. A method for comparative assessment of antioxidant as peroxyl radical scavengers. Biochem. Pharmacol. 38:1989;1645-1649.
17. Shimoni, E.; Armon, R.; Neeman, I. Antioxidant properties of deferoxamine. J. Am. Oil Chem. Soc. 71:641-464; 1994.
18. Rice-Evans C. A., Okunade G., Khan R. The suppression of iron release from activated myoglobin by physiological electron donors and desferrioxamine. Free Rad. Res. Comm. 7:1989;45-54.
19. Green E. S. R., Rice-Evans H., Rice-Evans P., Davies M. J., Salah N., Rice-Evans C. A. The efficacy of monohydroxamates as free radical scavenging agents compared with di- and tri-hydroxamates. Biochem. Pharmacol. 45:1993;357-366.
20. Cooper C. E., Green E. S. R., Rice-Evans C. A., Davies M. J., Wrigglesworth J. M. A hydrogen-donating monohydroxamate scavenges ferryl myoglobin radicals. Free Rad. Res. 20:1994;219-227.
21. Hartley A., Davies M. J., Rice-Evans C. A. Desferrioxamine as a chain breaking antioxidant in sickle cell membrane. FEBS Lett. 264:1990;145-148.
22. Grankvist K., Marklund S. L. Opposite effects of two metal-chelators on alloxan-induced diabetes in mice. Life Sci. 33:1983;2535-2540.
23. Borg D. C., Schaich K. M. Prooxidant action of desferrioxamine: Fenton-like production of hydroxyl radicals by reduced ferrioxamine. J. Free Rad. Biol. Med. 2:1986;237-243.
24. Klebanoff S. J., Waltersdorph A. M., Michel B. R., Rosen H. Oxygen-based free radical generation by ferrous iron and deferoxamine. J. Biol. Chem. 264:1989;19765-19771.
25. Mordente A., Meucci E., Miggiano G. A. D., Martorana G. E. Prooxidant action of desferrioxamine: Enhancement of alkaline phosphatase inactivation by interaction with ascorbate system. Arch. Biochem. Biophys. 277:1990;234-240.
26. De Matteis F., Dawson S. J., Gibbs A. H. Two pathways of iron-catalyzed oxidation of bilirubin: Effect of desferrioxamine and Trolox, and comparison with microsomal oxidation. Free Rad. Biol. Med. 15:1993;301-309.
27. 2 detection: Role of some reducing agents. Free Rad. Res. 23:1995;103-115.
28. Blobstein S. H., Grady R. W., Meshnick S. R., Cerami A. Hydroxamic acid oxidation - pharmacological considerations. Biochem. Pharmacol. 27:1978;2939-2945.
29. Van Reyk D. M., Dean R. T. The iron-selective chelator desferal can reduce chelated copper. Free Rad. Res. 24:1996;55-60.
30. 2-activated myoglobin. Free Rad. Res. Comm. 3:1987;309-317.
31. Morehouse K. M., Flitter W. D., Mason R. P. The enzymatic oxidation of desferal to a nitroxide free radical. FEBS Lett. 222:1987;246-250.
32. Soriani M., Mazzuca S., Quaresima V., Minetti M. Oxidation of desferrioxamine to nitroxide free radical by activated human neutrophils. Free Rad. Biol. Med. 14:1993;589-599.
33. Denicola A., Souza J. M., Gatti R. M., Augusto O., Radi R. Desferrioxamine inhibition of the hydroxyl radical-like reactivity of peroxynitrite: Role of hydroxamic groups. Free Rad. Biol. Med. 19:1995;11-19.
34. Van Ommen B., Adang A., Muller F., Van Bladeren P. J. The microsomal metabolism of pentachlorophenol and its covalent binding to protein and DNA. Chem-Biol. Interact. 60:1986;1-11.
35. Seiler J. P. Pentachlorophenol. Mutation Res. 257:1991;27-47.
36. Van Ommen B., Adang A. E. P., Brader L., Posthumus M. A., Muller F., Van Bladeren P. J. The microsomal metabolism of hexachlorobenzene. Biochem. Pharmacol. 35:1986;3233-3238.
37. Koss G., Losekam M., Seidel J., Steinbach K., Koransky W. Inhibitory effect of tetrachloro-p -hydroquinone and other metabolites of hexachlorobenzene on hepatic uroporphyrinogen decarboxylase activity with reference to the role of glutathione. Ann. N.Y. Acad. Sci. 514:1987;148-159.
38. Witte I., Juhl U., Butte W. DNA-damaging properties and cytotoxicity in human fibroblasts of tetrachlorohydroquinone, a pentachlorophenol metabolite. Mutation Res. 145:1985;71-75.
39. Carstens C. P., Blum J. K., Witte I. The role of hydroxyl radicals in tetrachlorohydroquinone induced DNA strand break formation in PM2 DNA and human fibroblasts. Chem-Biol. Interact. 74:1990;305-314.
40. Dahlhaus M., Almstadt E., Henschke P., Luttgert S., Appel K. E. Induction of 8-hydroxy-2-deoxyguanosine and single strand breaks in DNA of V79 cells by tetrachloro-p-hydroquinone. Mutation Res. 329:1995;29-36.
41. Dahlhaus M., Almstadt E., Henachke P., Luttgert S., Appel K. E. Oxidative DNA lesions in V79 cells mediated by pentachlorophenol metabolites. Arch. Toxicol. 70:1996;457-460.
42. Dahlhaus M., Almstadt E., Appel K. E. The pentachlorophenol metabolite tetrachloro-p-hydroquinone induces the formation of 8-hydroxy-2-deoxyguanosine in liver DNA of male B6C3F1 mice. Toxicol. Lett. 74:1994;265-274.
43. Naito S., Ono Y., Somiya I., Inoue S., Ito K., Yamamoto K., Kawanishi S. Role of active oxygen species in DNA damage by pentachlorophenol metabolites. Mutation Res. 310:1994;79-88.
44. Koppenol W. H., Butler J. Energetics in interconversion reactions of oxyradicals. Adv. Free Rad. Biol. Med. 1:1985;91-131.
45. Nohl H., Jordan W. The involvement of biological quinones in the formation of hydroxyl radicals via the Haber-Weiss reaction. Biorg. Chem. 15:1987;374-382.
46. Nohl H., Jordan W., Youngman R. J. Quinones in biology: Function in electron transfer and oxygen activation. Adv. Free Rad. Biol. Med. 2:1986;211-279.
47. Freedman N. H., Boyden M., Talor M., Skarf B. Neurotoxicity associated with deferoxamine therapy. Toxicology. 49:1988;283-290.
48. Lee Y. S., Wurster R. D. Deferoxamine-induced cytotoxicity in human neuronal cell lines: Protection by free radical scavengers. Toxicol. Lett. 78:1995;67-71.
49. Powis G. Free radical formation by antitumor quinones. Free Rad. Biol. Med. 6:1989;63-101.
50. Sarr D. H., Kazunga C., Charles M. J., Pavlovich J. G., Aitken M. D. Decomposition of tetrachloro-1,4-benzoquinone (P-chloranil) in aqueous solution. Environ. Sci. Technol. 29:1995;2735-2740.
51. Samokyszyn V. M., Freeman J. P., Maddipati K. R., Lloyd R. V. Peroxidase-catalyzed oxidation of pentachlorophenol. Chem. Res. Toxicol. 8:1995;349-355.
52. Chung N., Aust S. D. Veratryl alcohol-mediated indirect oxidation of pentachlorophenol by lignin peroxidase. Arch. Biochem. Biophys. 322:1995;143-148.
53. Ruckdeschel G., Renner G. Effects of pentachlorophenol and some of its known and possible metabolites on fungi. Appl. Environ. Microbiol. 51:1986;1370-1372.
54. Hammel K. E., Tardone P. J. The oxidative 4-dechlorination of polychlorinated phenols is catalyzed by extracelluar fungal lignin peroxidases. Biochemistry. 27:1988;6563-6568.
55. Waidyanatha S., McDonald T. A., Lin P. H., Rappaport S. M. Measurement of hemoglobin and albumin adducts of tetrachrobenzoquinone. Chem. Res. Toxicol. 7:1994;463-468.